These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 27010181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
    Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A.
    Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
    Mesquida M, Molins B, Llorenç V, Sainz de la Maza M, Adán A.
    Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
    [Abstract] [Full Text] [Related]

  • 4. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.
    Suelves AM, Arcinue CA, González-Martín JM, Kruh JN, Foster CS.
    Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800
    [Abstract] [Full Text] [Related]

  • 5. Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.
    Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A, Halim MS, Do DV, Nguyen QD.
    Am J Ophthalmol; 2017 Nov; 183():71-80. PubMed ID: 28887113
    [Abstract] [Full Text] [Related]

  • 6. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS.
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 9. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.
    Deuter CME, Zierhut M, Igney-Oertel A, Xenitidis T, Feidt A, Sobolewska B, Stuebiger N, Doycheva D.
    Ocul Immunol Inflamm; 2017 Apr; 25(2):215-220. PubMed ID: 26731514
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 11. Biologic therapies for inflammatory eye disease.
    Lim L, Suhler EB, Smith JR.
    Clin Exp Ophthalmol; 2006 Aug; 34(4):365-74. PubMed ID: 16764659
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A, Bielefeld P, Bidot S, Vinit J, Besancenot JF, Bron A.
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [Abstract] [Full Text] [Related]

  • 13. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, Sené T, Cochereau I, Titah C.
    Ocul Immunol Inflamm; 2021 Jan 02; 29(1):9-13. PubMed ID: 32643976
    [Abstract] [Full Text] [Related]

  • 14. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B, Calvo-Río V, Beltrán E, Martínez-Costa L, Valls-Pascual E, Hernández-Garfella M, Atanes A, Cordero-Coma M, Miquel Nolla J, Carrasco-Cubero C, Loricera J, González-Vela MC, Vegas-Revenga N, Fernández-Díaz C, Demetrio-Pablo R, Domínguez-Casas LC, Luis Martín-Varillas J, Palmou-Fontana N, Hernández JL, González-Gay MÁ, Blanco R.
    Rheumatology (Oxford); 2018 May 01; 57(5):856-864. PubMed ID: 29471416
    [Abstract] [Full Text] [Related]

  • 15. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
    Erkanli L, Akova YA, Guney-Tefekli E, Tugal-Tutkun I.
    Cornea; 2010 Jan 01; 29(1):26-33. PubMed ID: 19907295
    [Abstract] [Full Text] [Related]

  • 16. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI.
    Ophthalmology; 2013 Feb 01; 120(2):379-86. PubMed ID: 23177360
    [Abstract] [Full Text] [Related]

  • 17. Combination of Intravenous Methotrexate and Methylprednisolone Therapy in the Treatment of Severe Ocular Inflammatory Diseases.
    Maleki A, Ueberroth JA, Walsh M, Foster F, Chang PY, Anesi SD, Foster CS.
    Ocul Immunol Inflamm; 2021 Nov 17; 29(7-8):1559-1563. PubMed ID: 32406782
    [Abstract] [Full Text] [Related]

  • 18. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Díaz-Llopis M, Salom D, Garcia-de-Vicuña C, Cordero-Coma M, Ortega G, Ortego N, Suarez-de-Figueroa M, Rio-Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez-Del-Castillo JM, Olea JL, Arevalo JF.
    Ophthalmology; 2012 Aug 17; 119(8):1575-81. PubMed ID: 22525047
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate for ocular inflammatory diseases.
    Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study.
    Ophthalmology; 2009 Nov 17; 116(11):2188-98.e1. PubMed ID: 19748676
    [Abstract] [Full Text] [Related]

  • 20. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
    Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS.
    Arch Ophthalmol; 2007 Jul 17; 125(7):895-900. PubMed ID: 17620567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.